Production (Stage)
Pacific Biosciences of California, Inc.
PACB
$1.14
$0.1414.00%
NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -657.75M | -309.85M | -394.24M | -400.38M | -296.90M |
| Total Depreciation and Amortization | 414.12M | 53.35M | 54.10M | 43.46M | 34.03M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 86.82M | 91.02M | 163.86M | 156.25M | 63.88M |
| Change in Net Operating Assets | -17.62M | -40.58M | -56.69M | -52.01M | -41.18M |
| Cash from Operations | -174.43M | -206.06M | -232.97M | -252.69M | -240.16M |
| Capital Expenditure | -3.70M | -6.19M | -6.60M | -8.21M | -9.00M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | 0.00 | -102.00K | -102.00K |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 207.07M | 130.19M | 5.79M | 226.76M | 52.12M |
| Cash from Investing | 203.37M | 124.00M | -809.00K | 218.45M | 43.02M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -50.35M | -50.69M | -935.00K | -1.42M | -1.73M |
| Issuance of Common Stock | 2.77M | 7.70M | 8.64M | 12.39M | 14.98M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -50.20M | -50.20M | -82.09M | -86.95M | -93.79M |
| Cash from Financing | -47.58M | -42.99M | -74.39M | -75.98M | -80.55M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -18.64M | -125.04M | -308.17M | -110.22M | -277.69M |